Class II

Drug Recall: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Chiesi USA, Inc. · March 17, 2026

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

7,235 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0402-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.